These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 3930223

  • 21. Mediation by calcium of thyrotropin--releasing hormone action on the prolactin promoter via transcription factor pit-1.
    Yan GZ, Bancroft C.
    Mol Endocrinol; 1991 Oct; 5(10):1488-97. PubMed ID: 1775132
    [Abstract] [Full Text] [Related]

  • 22. Epidermal growth factor decreases the concentration of thyrotropin-releasing hormone (TRH) receptors and TRH responses in pituitary GH4C1 cells.
    Hinkle PM, Shanshala ED, Yan ZF.
    Endocrinology; 1991 Sep; 129(3):1283-8. PubMed ID: 1651844
    [Abstract] [Full Text] [Related]

  • 23. Phosphatidylinositol depletion in GH3 rat pituitary cells inhibits sustained responses to thyrotropin-releasing hormone. Reversal with myo-inositol.
    Rodriguez R, Imai A, Gershengorn MC.
    Mol Endocrinol; 1987 Nov; 1(11):802-7. PubMed ID: 3155260
    [Abstract] [Full Text] [Related]

  • 24. Defective thyroliberin-induced prolactin synthesis and release in a hybrid GH strain.
    Brennessel BA, Biswas DK.
    Mol Cell Biochem; 1984 Aug; 63(1):67-73. PubMed ID: 6092907
    [Abstract] [Full Text] [Related]

  • 25. Bombesin stimulates prolactin and growth hormone release by pituitary cells in culture.
    Westendorf JM, Schonbrunn A.
    Endocrinology; 1982 Feb; 110(2):352-8. PubMed ID: 6799271
    [Abstract] [Full Text] [Related]

  • 26. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
    Judd AM, Kubota T, Kuan SI, Jarvis WD, Spangelo BL, Macleod RM.
    Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
    [Abstract] [Full Text] [Related]

  • 27. Ca2+ and hormones interact synergistically to stimulate rapidly both prolactin production and overall protein synthesis in pituitary tumor cells.
    Brostrom MA, Brostrom CO, Bocckino SB, Green SS.
    J Cell Physiol; 1984 Nov; 121(2):391-401. PubMed ID: 6436256
    [Abstract] [Full Text] [Related]

  • 28. 1,25-Dihydroxycholecalciferol enhances both the bombesin-induced transient in intracellular free Ca2+ and the bombesin-induced secretion of prolactin in GH4C1 pituitary cells.
    Törnquist K.
    Endocrinology; 1991 Apr; 128(4):2175-82. PubMed ID: 1900787
    [Abstract] [Full Text] [Related]

  • 29. Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone.
    Martinez de la Escalera G, Weiner RI.
    Neuroendocrinology; 1988 Mar; 47(3):186-93. PubMed ID: 3129665
    [Abstract] [Full Text] [Related]

  • 30. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
    Delbeke D, Dannies PS.
    Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
    [Abstract] [Full Text] [Related]

  • 31. Multiple intracellular signallings are involved in thyrotropin-releasing hormone (TRH)-induced c-fos and jun B mRNA levels in clonal prolactin cells.
    Passegue E, Richard JL, Boulla G, Gourdji D.
    Mol Cell Endocrinol; 1995 Jan; 107(1):29-40. PubMed ID: 7796933
    [Abstract] [Full Text] [Related]

  • 32. Intracellular calcium concentration and hormone secretion are controlled differently by TRH in rat neonatal lactotrophs and somatotrophs.
    Lorsignol A, Taupignon A, Horvath G, Dufy B.
    J Endocrinol; 1997 Sep; 154(3):483-94. PubMed ID: 9379126
    [Abstract] [Full Text] [Related]

  • 33. Modulation by 1,25-dihydroxycholecalciferol of the acute change in cytosolic free calcium induced by thyrotropin-releasing hormone in GH4C1 pituitary cells.
    Chisholm JC, Kim S, Tashjian AH.
    J Clin Invest; 1988 Mar; 81(3):661-8. PubMed ID: 2830313
    [Abstract] [Full Text] [Related]

  • 34. Thyrotropin-releasing hormone (TRH) stimulates biphasic elevation of cytoplasmic free calcium in GH3 cells. Further evidence that TRH mobilizes cellular and extracellular Ca2+.
    Gershengorn MC, Thaw C.
    Endocrinology; 1985 Feb; 116(2):591-6. PubMed ID: 3917906
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the forms of the dopamine D2 receptor expressed in GH4C1 cells.
    Burris TP, Freeman ME.
    Proc Soc Exp Biol Med; 1994 Mar; 205(3):226-35. PubMed ID: 8171043
    [Abstract] [Full Text] [Related]

  • 36. Pituitary thyrotropin-releasing hormone (TRH) receptors: effects of TRH, drugs mimicking TRH action, and chlordiazepoxide.
    Hinkle PM, Shanshala ED.
    Mol Endocrinol; 1989 Sep; 3(9):1337-44. PubMed ID: 2481818
    [Abstract] [Full Text] [Related]

  • 37. Thyrotropin-releasing hormone and phorbol esters induce phosphatidylcholine synthesis in GH3 pituitary cells. Evidence for stimulation via protein kinase C.
    Kolesnick RN.
    J Biol Chem; 1987 Oct 25; 262(30):14525-30. PubMed ID: 3117787
    [Abstract] [Full Text] [Related]

  • 38. Voltage-dependent calcium channels in pituitary cells in culture. II. Participation in thyrotropin-releasing hormone action on prolactin release.
    Tan KN, Tashjian AH.
    J Biol Chem; 1984 Jan 10; 259(1):427-34. PubMed ID: 6323410
    [Abstract] [Full Text] [Related]

  • 39. Fura-2 imaging of thyrotropin-releasing hormone and dopamine effects on calcium homeostasis of bovine lactotrophs.
    Akerman SN, Zorec R, Cheek TR, Moreton RB, Berridge MJ, Mason WT.
    Endocrinology; 1991 Jul 10; 129(1):475-88. PubMed ID: 1905229
    [Abstract] [Full Text] [Related]

  • 40. GH4 pituitary cell variants selected as nonresponsive to thyrotropin-releasing hormone-enhanced substratum adhesion are nonresponsive to epidermal growth factor: evidence for a common signaling defect.
    Ramsdell JS, Tashjian AH.
    J Cell Physiol; 1989 Dec 10; 141(3):565-72. PubMed ID: 2480354
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.